Beijing Bohui Innovation Biotechnology Group Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 597.41 million compared to CNY 532.01 million a year ago. Revenue was CNY 597.41 million compared to CNY 532.01 million a year ago.

Net loss was CNY 39.32 million compared to CNY 28.21 million a year ago. Basic loss per share from continuing operations was CNY 0.0481 compared to CNY 0.0345 a year ago. Diluted loss per share from continuing operations was CNY 0.0481 compared to CNY 0.0345 a year ago.